menu
    • menu

    Company profile for Endonovo Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Endonovo Therapeutics (OTCQB: ENDV) is a commercial-stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical® Therapy for the treatment of inflammatory conditions, cardiovascular diseases, and central nervous system disorders. Endonovo's Electroceutical® Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of ...
    Endonovo Therapeutics (OTCQB: ENDV) is a commercial-stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical® Therapy for the treatment of inflammatory conditions, cardiovascular diseases, and central nervous system disorders. Endonovo's Electroceutical® Therapy is FDA-Cleared for the palliative treatment of pain and post-surgical edema (swelling) and CE Marked for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. Endonovo's Electroceutical® Therapy has CMS National Coverage for the treatment of chronic wounds.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Endonovo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6320 Canoga Avenue, 15th Floor Woodland Hills, CA 91367
    Telephone
    Telephone
    +1 8007011223
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://endonovo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/endonovo-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse
    Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2854076/0/en/Endonovo-Closes-Asset-Purchase-Agreement-for-a-Minimum-of-50M-With-SofPulse-Inc.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Endonovos SofPulse® to Be Featured at Innovative Pain Management Solutions
    Endonovos SofPulse® to Be Featured at Innovative Pain Management Solutions

    04 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/04/2839681/0/en/Endonovo-s-SofPulse-to-Be-Featured-at-Innovative-Pain-Management-Solutions.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share
    Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business
    Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business

    04 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/04/2790115/0/en/Endonovo-Signs-Definitive-Agreement-to-Sell-SofPulse-Brand-Business-and-IP-to-SofPulse-Inc-for-a-minimum-of-50-Million.html

    GLOBENEWSWIRE
    04 Dec 2023
    Share Share
    Endonovo's SofPulse® Secures Taiwan FDA Approval
    Endonovo's SofPulse® Secures Taiwan FDA Approval

    12 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/12/2759320/0/en/Endonovo-s-SofPulse-Secures-Taiwan-FDA-Approval.html

    GLOBENEWSWIRE
    12 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search